Characteristics | Number of cases n = 47 |
---|---|
Infection | |
Early (≤ 30 days) | 6 (12.8) |
Late (> 30 days) | |
31-90 days | 11 (23.4) |
91-365 days | 17 (36.2) |
> 365 days | 5 (10.6) |
– Local recurrence of breast cancer | 2 (4.3) |
– Local recurrence of breast cancer in the chest wall | 2 (4.3) |
– Postoperative pain | 1 (2.1) |
– Leakage of prosthesis/expander prosthesis | 2 (4.3) |
– No data | 1 (2.1) |
Characteristics | Number of cases n = 47 |
---|---|
Ductal carcinoma | 36 (76.6) |
Lobular carcinoma | 2 (4.3) |
Other forms of invasive cancer | 3 (6.4) |
DCIS | 4 (8.5) |
No data | 2 (4.3) |
IA | 14 (29.8) |
IIA | 17 (36.2) |
IIB | 5 (10.6) |
IIIA | 2 (4.3) |
IIIB | 1 (2.1) |
No data | 8 (17.0) |
Yes | 3 (6.4) |
No | 44 (93.6) |
Yes | 2 (4.3) |
No | 36 (76.6) |
No data | 9 (19.1) |
< 25 | 21 (44.7) |
≥ 25 | 26 (55.3) |
Yes | 8 (17.0) |
No | 26 (55.3) |
No data | 13 (27.7) |
Immediate | 20 (42.6) |
Deferred | 27 (57.4) |
Expander | 23 (48.9) |
Expander prosthesis | 8 (17.0) |
Prosthesis | 5 (10.6) |
Expander prosthesis/prosthesis (2nd stage of reconstruction - replacement of implant after earlier implantation of expander) | 11 (23.4) |
Characteristic | Number of cases n = 47 |
---|---|
Pre-implantation treatment: | |
– RTH | 1 (2.1) |
– CHTH | 13 (27.7) |
– RTH+CHTH | 13 (27.7) |
– No treatment | 19 (40.4) |
– No data | 1 (2.1) |
Post-implantation treatment: | |
– RTH | 1 (2.1) |
– CHTH | 4(8.5) |
– RTH+CHTH | 1 (2.1) |
– No treatment | 40 (85.1) |
– No data | 1 (2.1) |